The early assessment of the systemic inflammatory response syndrome score is able to predict acute graft-versus-host disease and non-relapse mortality in patients undergoing an allogeneic stem cell transplantation

被引：0
|
作者：
De Philippis, C. [1 ]
Spina, F. [1 ]
Farina, L. [1 ]
Roncari, L. [1 ]
Soldarini, M. [1 ]
Dodero, A. [1 ]
Montefusco, V. [1 ]
Perrone, G. [1 ]
Corradini, P. [2 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Hematol, Milan, Italy
[2] Univ Milan, Hematol, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O061
引用
收藏
页码：S36 / S37
页数：2
相关论文
共 50 条
  • [1] THE EARLY ASSESSMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME SCORE IS ABLE TO PREDICT ACUTE GRAFT-VERSUS HOST DISEASE AND NON-RELAPSE MORTALITY IN PATIENTS AFFECTED BY HAEMATOLOGICAL DISEASES UNDERGOING AN ALLOGENEIC STEM CELL TRANSPLANTATION
    De Philippis, C.
    Spina, F.
    Farina, L.
    Roncari, L.
    Soldarini, M.
    Dodero, A.
    Montefusco, V.
    Perrone, G.
    Corradini, P.
    HAEMATOLOGICA, 2015, 100 : 114 - 115
  • [2] THE EARLY ASSESSMENT OF THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) SCORE IS ABLE TO PREDICT ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING AN ALLOGENEIC STEM CELL TRANSPLANTATION
    Farina, L.
    Manuelli, M.
    De Philippis, C.
    Spina, F.
    Rezzonico, F.
    Roncari, L.
    Perrone, G.
    Corradini, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S545 - S546
  • [3] Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation
    Shin, Junghoon
    Dan, Kisoon
    Han, Dohyun
    Kim, Ji-Won
    Kim, Kyung Kon
    Koh, Youngil
    Shin, Dong-Yeop
    Hong, Junshik
    Yoon, Sung-Soo
    Park, Seonyang
    Song, Sang Hoon
    Kim, Inho
    BLOOD CELLS MOLECULES AND DISEASES, 2019, 74 : 5 - 12
  • [4] Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
    Kekre, Natasha
    Kim, Haesook T.
    Ho, Vincent T.
    Cutler, Corey
    Armand, Philippe
    Nikiforow, Sarah
    Alyea, Edwin P.
    Soiffer, Robert J.
    Antin, Joseph H.
    Connors, Jean M.
    Koreth, John
    HAEMATOLOGICA, 2017, 102 (07) : 1185 - 1191
  • [5] Pre-engraftment serum C-reactive protein value may predict acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic myeloablative haematopoietic stem cell transplantation
    Fuji, S.
    Kim, S.
    Mori, S.
    Fukuda, T.
    Tanosaki, R.
    Heike, Y.
    Tobinai, K.
    Takaue, Y.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S108 - S109
  • [6] Liver stiffness assessed before hematopoietic stem cell transplantation predicts graft-versus-host disease and non-relapse mortality
    Cabirta, A.
    Riveiro-Barciela, M.
    Navarro, V.
    Barba, P.
    Fox, L.
    Salamero, O.
    Barreira-Diaz, A.
    Garcia-Guinon, A.
    Roldan, E.
    Perez, A.
    Roade-Tato, L.
    Molero, A.
    Catala, E.
    Bosch, F.
    Orti, G.
    Buti, M.
    Valcarcel, D.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 74 - 75
  • [7] Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality
    S Chakrabarti
    A Lees
    SG Jones
    DW Milligan
    Bone Marrow Transplantation, 2000, 26 : 871 - 876
  • [8] Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality
    Chakrabarti, S
    Lees, A
    Jones, SG
    Milligan, DW
    BONE MARROW TRANSPLANTATION, 2000, 26 (08) : 871 - 876
  • [9] Allogeneic Stem Cell Transplantation after Exposure to Checkpoint Inhibitors: Graft Versus Host Disease and Non-Relapse Mortality in Pooled Analysis
    Dada, Reyad
    Binyam, Usman
    BLOOD, 2018, 132
  • [10] HIGH RATES OF NON-RELAPSE MORTALITY AND GRAFT-VERSUS-HOST DISEASE IN PATIENT UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION (ASCT) FOLLOWING NON-MYELOABLATIVE (NMA) CONDITIONING WITH TLI/ATG
    Kanate, A. S.
    Chaudhary, L.
    Cumpston, A.
    Leadmon, S.
    Bunner, P.
    Bulian, D.
    Gibson, L.
    Tse, W.
    Abraham, J.
    Remick, S.
    Craig, M.
    Hamadani, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S313 - S313
12345